OpinionJuly 12, 2020
The Power of Psychedelics
They worked for my depression. Could they be the future of psychiatry?
Stories by Erica Rex
Erica Rex has written for Scientific American, The New York Times, The Times (UK), The Independent, Salon, The Economist and many other publications. She is a recipient of National Magazine Award for Fiction. She is working on a book about PTSD, depression, and the reintroduction of psychedelic drugs as therapy.
EnvironmentDecember 9, 2013
European Coastal Defenses May Reduce Destruction from Epic Storm
The wind and waves from the 50-year storm halted travel and disrupted lives
September 10, 2013
Warming Climate Begins to Taint Europe's Blood
Tropical diseases have begun appearing in Europe anew, raising concerns about donated blood
EnvironmentJune 10, 2013
Climate Change May Bring Severe Flooding to Some Regions
New models show how global warming may increase flooding from southeast Asia to western Europe
May 23, 2013
Will Great Wines Prove a Moveable Feast under Global Warming?
What wine grapes grow in which part of the world is changing—and will continue to change
May 1, 2013
Hallucinogens Could Ease Existential Terror
Psilocybin, the active ingredient in magic mushrooms, is being explored as a therapeutic tool to improve the lives of people with a life-threatening illness
EnvironmentJanuary 8, 2013
Harmful Algal Blooms Increase as Lake Water Warms
Increasing temperatures as a result of climate change have aided blooms of algae
EvolutionAugust 13, 2012
Invasive Fungi Wreak Havoc on Species Worldwide [Slide Show]
Human activity like trade has helped launch a deadly wave of fungal disease
The SciencesJuly 12, 2010
Skin Fight: Could Bacteria Carried by Amphibians Save Them from Extinction?
Symbiotic bacteria may help frogs and other amphibians ward off the chytrid fungus plague wiping out populations worldwide
HealthJune 24, 2010
Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment
As researchers learn more about genetic profile of various cancers, other work is charging ahead to deliver personalized vaccines targeted to a patient's own tumor cells